Episode of harmful use of MDMA or related drugs, including MDA

Description

An episode of use of MDMA or related drugs, including MDA, that has caused damage to a person’s physical or mental health or has resulted in behaviour leading to harm to the health of others. Harm to health of the individual occurs due to one or more of the following: (1) behaviour related to intoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) a harmful route of administration. Harm to health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behaviour due to intoxication with MDMA or related drugs, including MDA, on the part of the person to whom the diagnosis of single episode of harmful use applies. This diagnosis should not be made if the harm is attributed to a known pattern of use of MDMA or related drugs, including MDA.

Index terms

Episode of harmful use of MDMA or related drugs, including MDA
Single episode of harmful use of ecstasy or related drugs

Excludes

6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA
6C4C.2 – MDMA or related drug dependence, including MDA

Exclusions from above levels

QE11.6 – Hazardous use of MDMA or related drugs
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6C4C.1 – Harmful pattern of use of MDMA or related drugs, including MDA
6C4C.2 – MDMA or related drug dependence, including MDA
6C4C.3 – MDMA or related drug intoxication, including MDA
6C4C.4 – MDMA or related drug withdrawal, including MDA
6C4C.5 – MDMA or related drug-induced delirium, including MDA
6C4C.6 – MDMA or related drug-induced psychotic disorder, including MDA
6C4C.7 – Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
6C4C.Y – Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
6C4C.Z – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified

Foundation entity

Episode of harmful use of MDMA or related drugs, including MDA – http://id.who.int/icd/entity/1334295394

Allowed postcoordination axes

Part of: 6C4C: Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] › 06: Mental, behavioural or neurodevelopmental disorders